devdiscourse4h
FDA Greenlights Vyloy for Gastric Cancer, Egypt Achieves Malaria-Free Status
The FDA has approved Astellas' Vyloy to treat gastric cancer. Egypt has been certified malaria-free by WHO. A Tennessee court ...
Targeted Oncology7h
The Targeted Pulse: Explore How a Community Practice Implemented Bispecific Antibody Therapy and Key Updates in Cancer Treatments
Promising results from the anti–LAG-3/anti–PD-1 combo for melanoma, FDA approval of inavolisib for PIK3CA-mutant breast cancer, significant survival benefits from talazoparib and enzalutamide in ...
healthandpharma9h
FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer
The FDA has approved zolbetuximab-clzb (VYLOY) as a first-line targeted therapy, in combination with chemotherapy, for the ...
The reality of breast cancer in men
Breast cancer in men can be misdiagnosed or overlooked because it’s so rare, but early detection can be lifesaving.
Roche receives FDA approval for Ventana CLDN18 RxDx Assay
Roche (RHHBY) announced that the VENTANA CLDN18 RxDx Assay is the first U.S. Food and Drug Administration approved ...
Hosted on MSN19h
Local hospital sells research achievements for more than US$13.77 million
Zhongshan Hospital's achievements cover reagents for different types of cancer, cardiopathy and more. The agreements help speed up the commercialization of scientific research.
devdiscourse21h
Health Sector Headlines: From FDA Approvals to CEO Transitions
Recent health news includes FDA's approval of Astellas' gastric cancer therapy, the resignation of CVS Health CEO Karen Lynch ...